Connor, Clark & Lunn Investment Management (CC&L)
ANAC

Connor, Clark & Lunn Investment Management (CC&L)’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-30,500
Closed -$2.36M – 851
2015
Q2 		$2.36M Buy
30,500
+8,000
+36% +$525K 0.02% 219
2015
Q1 		$1.3M Buy
22,500
+2,600
+13% +$110K 0.01% 278
2014
Q4 		$642K Buy
19,900
+7,600
+62% +$228K 0.01% 356
2014
Q3 		$301K Buy
+12,300
New +$250K ﹤0.01% 455

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

Connor, Clark & Lunn Investment Management (CC&L)'s ANAC Position: Q3 2015 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q3 2015, closing a stake of 30,500 shares — an estimated $2.36M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ANAC in Q3 2014 and held it in 4 quarters. The position peaked at $2.36M in Q2 2015. 213 funds tracked by Wall St. Rank hold ANAC as of Q3 2015.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q3 2015 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 30,500 ANACOR PHARMACEUTICALS INC COM shares in Q3 2015, an estimated $2.36M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2014 and held it in 4 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ANACOR PHARMACEUTICALS INC COM position peaked at $2.36M in Q2 2015.
  • 213 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q3 2015.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2015, filed 13 Nov 2015.